Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice

Biosci Biotechnol Biochem. 2014;78(3):482-9. doi: 10.1080/09168451.2014.882753. Epub 2014 Apr 14.

Abstract

A Vigna nakashimae (VN) extract has been shown to have antidiabetic and anti-obesity effects. However, the mechanism underlying the effect of a VN extract on hepatic inflammation and endoplasmic reticulum (ER) stress remains unclear. In the present study, we investigated how a VN extract protects against the development of non-alcoholic fatty liver disease (NAFLD). A VN extract for 12 weeks reduced the body weight, serum metabolic parameters, cytokines, and hepatic steatosis in high-fat diet (HFD)-fed mice. A VN extract decreased HFD-induced hepatic acetyl CoA carboxylase and glucose transporter 4 expressions. In addition to the levels of high-mobility group box 1 and receptor for advanced glycation, the hepatic expression of ATF4 and caspase-3 was also reduced by a VN extract. Thus, these data indicate that a chronic VN extract prevented NAFLD through multiple mechanisms, including inflammation, ER stress, and apoptosis in the liver.

Keywords: Vigna nakashimae; endoplasmic reticulum stress; inflammation; nonalcoholic fatty liver disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyl-CoA Carboxylase / biosynthesis
  • Animals
  • Apoptosis / drug effects
  • Diet, High-Fat
  • Fabaceae / chemistry*
  • Gene Expression Regulation / drug effects
  • Glucose Transporter Type 4 / biosynthesis
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / metabolism
  • Inflammation / pathology
  • Lipid Metabolism / drug effects
  • Mice
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology
  • Plant Extracts / administration & dosage*
  • Plant Extracts / chemistry

Substances

  • Glucose Transporter Type 4
  • Plant Extracts
  • Acetyl-CoA Carboxylase